Financials
Financial year 2025
THALEN BIOTECH CONSULTANCY from Frasnes-lez-Anvaing, company number BE0607985607, closed financial year 2025 with a result of € 166,089 after tax. For that financial year THALEN BIOTECH CONSULTANCY recorded a gross margin of € 221,552 and equity of € 18,550. Compared with financial year 2024, the result moved from € 155,502 to € 166,089. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
€ 18,550
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 166,089
▲ 7% vs 2024
Profit after tax over the fiscal year.
€ 167,800
▲ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 166,089 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 312
▼ 46% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,318
▲ 63% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 34,435
▲ 101% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 167,614 | € 195,137 | € 207,380 | € 221,552 | ▲ 7% |
| Profit after taxes | € 129,275 | € 146,954 | € 155,502 | € 166,089 | ▲ 7% |
| Equity | € 20,405 | € 18,550 | € 18,550 | € 18,550 | |
| Total debts | € 196,431 | € 170,545 | € 178,289 | € 197,000 | ▲ 10% |
| Cash | € 126,815 | € 131,565 | € 137,062 | € 167,800 | ▲ 22% |
| Retained profit | € 1,855 | € 0 | € 0 | € 0 | |
| Dividend | € 129,275 | € 148,809 | € 155,502 | € 166,089 | ▲ 7% |
| Balance sheet total | € 216,836 | € 189,095 | € 196,839 | € 215,550 | ▲ 10% |
Key figures of THALEN BIOTECH CONSULTANCY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to THALEN BIOTECH CONSULTANCY?
What happened at THALEN BIOTECH CONSULTANCY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 166,089 (▲ 7% vs 2024). Source: NBB ↗
- New establishment in Rumes. KBO
- Start of the company according to the CBE. KBO
In short
From € 129,275 profit in 2022 to € 166,089 profit in 2025.
Paid € 180,474 in corporate taxes since 2022.
Best year ever: 2025, with € 166,089 profit.
Paid out € 599,675 in dividends to the owners in total.
Management
Behind THALEN BIOTECH CONSULTANCY is Marcel THALEN. Marcel THALEN is also behind BioLyo Technologies.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Bois de Martimont(FB) 7
7911 Frasnes-lez-Anvaing
Rue Royale(LG) 10
7611 Rumes
Active since 25 March 2015
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0607.985.607
- VAT number
- BE 0607.985.607
- Registered office
- Bois de Martimont(FB) 7, 7911 Frasnes-lez-Anvaing
- Names & denominations
- THALEN BIOTECH CONSULTANCY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 March 2015
- Peppol
- Active · Active since 19 Nov 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied